Omnicell Partners with SHPA to Launch First Australia 2021 Pharmacy Forecast Report
Omnicell Inc (NASDAQ:OMCL), a leading provider of supply and medication management solutions and adherence tools for healthcare systems and pharmacies, today joined the Society for Hospital Pharmacists Australia (SHPA) to launch the Australian 2021 Pharmacy Forecast.
This inaugural report from SHPA will provide hospital pharmacy leaders and their healthcare colleagues with valuable insight that has been informed by the latest thinking of their peers. The final recommendations in the report are a result of collating a diverse range of feedback from industry experts.
As the sponsor of the report, in conjunction with their local Australian Business Partner, Meditec, Omnicell joined pharmacy leaders from SHPA at a virtual event today to give an overview of the forecast to pharmacy leaders across Australia. Omnicell’s General Manager for the Asia Pacific region, Matt Hill, joined a panel of experts to provide an overview of the strategic insight included in the report.
“Omnicell is proud to support SHPA in this annual report to provide Australia’s pharmacy executives strategic direction for pharmacy practice so they can navigate the changing healthcare landscape.” explains Matt.
“We want to support pharmacists with the best practices and latest thinking around innovation and the need to adapt. Following the fallout of the Covid-19 pandemic this has never been more important. The forecast provides the opportunity for pharmacists to discuss the unique challenges they face and identify potential solutions.”
Russell Levy, Director of Pharmacy, Royal Prince Alfred Hospital, and Chair of the SHPA Pharmacy Forecast Advisory Committee, said: “It’s vital that we start discussing what strategies we need for our hospitals to become smarter after a very difficult period for healthcare. There is a wealth of knowledge out there in Australia and it is important we harness that information and expertise and share it. The support we have had from Omnicell has helped us to create what will be a very valuable tool when it comes to shaping the future of pharmacy in Australia.
